Home > Pharmaceuticals and Healthcare > North America Subcutaneous Immunoglobulins Market by Manufacturers, Countries, Type and Application, Forecast to 2022...

North America Subcutaneous Immunoglobulins Market by Manufacturers, Countries, Type and Application, Forecast to 2022

No. of Pages: 116Published : 16 Jan 2018

Request Sample
 

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump). Scope of the Report: This report focuses on the Subcutaneous Immunoglobulins in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Shire (Baxalta) Grifols CSL Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers 10% Purity 20% Purity Market Segment by Applications, can be divided into Primary Immunodeficiency Secondary Immunodeficiency Others There are 15 Chapters to deeply display the North America Subcutaneous Immunoglobulins market. Chapter 1, to describe Subcutaneous Immunoglobulins Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Subcutaneous Immunoglobulins, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Subcutaneous Immunoglobulins, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Subcutaneous Immunoglobulins market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Subcutaneous Immunoglobulins Research Findings and Conclusion, Appendix, methodology and data source

 

Table of Contents 1 Market Overview 1.1 Subcutaneous Immunoglobulins Introduction 1.2 Market Analysis by Type 1.2.1 10% Purity 1.2.2 20% Purity 1.3 Market Analysis by Applications 1.3.1 Primary Immunodeficiency 1.3.2 Secondary Immunodeficiency 1.3.3 Others 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Mexico Status and Prospect (2012-2022) 1.4.3 Canada Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Shire (Baxalta) 2.1.1 Profile 2.1.2 Subcutaneous Immunoglobulins Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Shire (Baxalta) News 2.2 Grifols 2.2.1 Profile 2.2.2 Subcutaneous Immunoglobulins Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Grifols News 2.3 CSL 2.3.1 Profile 2.3.2 Subcutaneous Immunoglobulins Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 CSL News 3 North America Subcutaneous Immunoglobulins Market Competition, by Manufacturer 3.1 North America Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer (2016-2017) 3.2 North America Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer (2016-2017) 3.3 North America Subcutaneous Immunoglobulins Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share 3.4.2 Top 5 Subcutaneous Immunoglobulins Manufacturer Market Share 3.5 Market Competition Trend 4 North America Subcutaneous Immunoglobulins Market Analysis by Countries 4.1 North America Subcutaneous Immunoglobulins Sales Market Share by Countries 4.2 North America Subcutaneous Immunoglobulins Sales by Countries (2012-2017) 4.3 North America Subcutaneous Immunoglobulins Revenue (Value) by Countries (2012-2017) 5 North America Market Segmentation Subcutaneous Immunoglobulins by Type 5.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2012-2017) 5.1.1 North America Subcutaneous Immunoglobulins Sales and Market Share by Type (2012-2017) 5.1.2 North America Subcutaneous Immunoglobulins Revenue and Market Share by Type (2012-2017) 5.2 10% Purity Sales Growth and Price 5.2.1 North America 10% Purity Sales Growth (2012-2017) 5.2.2 North America 10% Purity Price (2012-2017) 5.3 20% Purity Sales Growth and Price 5.3.1 North America 20% Purity Sales Growth (2012-2017) 5.3.2 North America 20% Purity Price (2012-2017) 6 North America Market Segmentation Subcutaneous Immunoglobulins by Application 6.1 North America Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017) 6.2 Primary Immunodeficiency Sales Growth (2012-2017) 6.3 Secondary Immunodeficiency Sales Growth (2012-2017) 6.4 Others Sales Growth (2012-2017) 7 United States Subcutaneous Immunoglobulins Sales, Revenue, by Type, Application and Manufacturers 7.1 United States Subcutaneous Immunoglobulins Revenue, Sales and Growth Rate (2012-2017) 7.2 United States Subcutaneous Immunoglobulins Sales and Market Share by Type 7.3 United States Subcutaneous Immunoglobulins Sales by Application (2012-2017) 7.4 United States Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Manufacturer 7.4.1 United States Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer 7.4.2 United States Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer 7.5 United States Subcutaneous Immunoglobulins Export and Import (2012-2017) 8 Canada Subcutaneous Immunoglobulins Sales, Revenue, by Type, Application and Manufacturers 8.1 Canada Subcutaneous Immunoglobulins Revenue, Sales and Growth Rate (2012-2017) 8.2 Canada Subcutaneous Immunoglobulins Sales and Market Share by Type 8.3 Canada Subcutaneous Immunoglobulins Sales by Application (2012-2017) 8.4 Canada Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Manufacturer 8.4.1 Canada Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer 8.4.2 Canada Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer 8.5 Canada Subcutaneous Immunoglobulins Export and Import (2012-2017) 9 Mexico Subcutaneous Immunoglobulins Sales, Revenue, by Type, Application and Manufacturers 9.1 Mexico Subcutaneous Immunoglobulins Revenue, Sales and Growth Rate (2012-2017) 9.2 Mexico Subcutaneous Immunoglobulins Sales and Market Share by Type 9.3 Mexico Subcutaneous Immunoglobulins Sales by Application (2012-2017) 9.4 Mexico Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Manufacturer 9.4.1 Mexico Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer 9.4.2 Mexico Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer 9.5 Mexico Subcutaneous Immunoglobulins Export and Import (2012-2017) 10 Subcutaneous Immunoglobulins Market Forecast (2017-2022) 10.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2017-2022) 10.2 Subcutaneous Immunoglobulins Market Forecast by Countries (2017-2022) 10.2.1 United States Subcutaneous Immunoglobulins Forecast (2017-2022) 10.2.2 Canada Subcutaneous Immunoglobulins Forecast (2017-2022) 10.2.3 Mexico Subcutaneous Immunoglobulins Forecast (2017-2022) 10.3 Subcutaneous Immunoglobulins Market Forecast by Type (2017-2022) 10.4 Subcutaneous Immunoglobulins Market Forecast by Application (2017-2022) 11 Subcutaneous Immunoglobulins Manufacturing Cost Analysis 11.1 Subcutaneous Immunoglobulins Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Subcutaneous Immunoglobulins 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Subcutaneous Immunoglobulins Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Subcutaneous Immunoglobulins Major Manufacturers in 2016 12.4 Downstream Buyers 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source

List of Tables and Figures Figure Subcutaneous Immunoglobulins Picture Table Product Specifications of Subcutaneous Immunoglobulins Figure North America Sales Market Share of Subcutaneous Immunoglobulins by Types in 2016 Table Types of Subcutaneous Immunoglobulins Figure 10% Purity Picture Table Major Manufacturers of 10% Purity Figure 20% Purity Picture Table Major Manufacturers of 20% Purity Table North America Subcutaneous Immunoglobulins Sales Market Share by Applications in 2016 Table Applications of Subcutaneous Immunoglobulins Figure Primary Immunodeficiency Picture Figure Secondary Immunodeficiency Picture Figure Others Picture Figure United States Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022) Figure Mexico Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022) Figure Canada Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022) Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors Table Shire (Baxalta) Subcutaneous Immunoglobulins Type and Applications Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Grifols Basic Information, Manufacturing Base and Competitors Table Grifols Subcutaneous Immunoglobulins Type and Applications Table Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table CSL Basic Information, Manufacturing Base and Competitors Table CSL Subcutaneous Immunoglobulins Type and Applications Table CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table North America Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017) Figure North America Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016 Figure North America Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017 Table North America Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017) Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016 Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017 Table North America Subcutaneous Immunoglobulins Price by Manufacturers (2016-2017) Figure Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share in 2016 Figure Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017 Figure Top 5 Subcutaneous Immunoglobulins Manufacturer Market Share in 2016 Figure Top 5 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017 Figure North America Subcutaneous Immunoglobulins Sales and Growth (2012-2017) Table North America Subcutaneous Immunoglobulins Sales by Countries (2012-2017) Table North America Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017) Figure North America 2012 Subcutaneous Immunoglobulins Sales Market Share by Countries Figure North America 2016 Subcutaneous Immunoglobulins Sales Market Share by Countries Figure North America Subcutaneous Immunoglobulins Revenue and Growth (2012-2017) Table North America Subcutaneous Immunoglobulins Revenue by Countries (2012-2017) Table North America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017) Table North America 2012 Subcutaneous Immunoglobulins Revenue Market Share by Countries Table North America 2016 Subcutaneous Immunoglobulins Revenue Market Share by Countries Table North America Subcutaneous Immunoglobulins Sales by Type (2012-2017) Table North America Subcutaneous Immunoglobulins Sales Share by Type (2012-2017) Table North America Subcutaneous Immunoglobulins Revenue by Type (2012-2017) Table North America Subcutaneous Immunoglobulins Revenue Share by Type (2012-2017) Figure North America 10% Purity Sales Growth (2012-2017) Figure North America 10% Purity Price (2012-2017) Figure North America 20% Purity Sales Growth (2012-2017) Figure North America 20% Purity Price (2012-2017) Table North America Subcutaneous Immunoglobulins Sales by Application (2012-2017) Table North America Subcutaneous Immunoglobulins Sales Share by Application (2012-2017) Figure North America Primary Immunodeficiency Sales Growth (2012-2017) Figure North America Secondary Immunodeficiency Sales Growth (2012-2017) Figure North America Others Sales Growth (2012-2017) Figure United States Subcutaneous Immunoglobulins Revenue and Growth (2012-2017) Figure United States Subcutaneous Immunoglobulins Sales and Growth (2012-2017) Table United States Subcutaneous Immunoglobulins Sales by Type (2012-2017) Table United States Subcutaneous Immunoglobulins Sales Market Share by Type (2012-2017) Table United States Subcutaneous Immunoglobulins Sales by Application (2012-2017) Table United States Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017) Table United States Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017) Figure United States Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016 Figure United States Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017 Table United States Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017) Figure United States Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016 Figure United States Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017 Table United States Subcutaneous Immunoglobulins Export and Import (2012-2017) Figure Canada Subcutaneous Immunoglobulins Revenue and Growth (2012-2017) Figure Canada Subcutaneous Immunoglobulins Sales and Growth (2012-2017) Table Canada Subcutaneous Immunoglobulins Sales by Type (2012-2017) Table Canada Subcutaneous Immunoglobulins Sales Market Share by Type (2012-2017) Table Canada Subcutaneous Immunoglobulins Sales by Application (2012-2017) Table Canada Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017) Table Canada Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017) Figure Canada Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016 Figure Canada Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017 Table Canada Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017) Figure Canada Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016 Figure Canada Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017 Table Canada Subcutaneous Immunoglobulins Export and Import (2012-2017) Figure Mexico Subcutaneous Immunoglobulins Revenue and Growth (2012-2017) Figure Mexico Subcutaneous Immunoglobulins Sales and Growth (2012-2017) Table Mexico Subcutaneous Immunoglobulins Sales by Type (2012-2017) Table Mexico Subcutaneous Immunoglobulins Sales Market Share by Type (2012-2017) Table Mexico Subcutaneous Immunoglobulins Sales by Application (2012-2017) Table Mexico Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017) Table Mexico Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017) Figure Mexico Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016 Figure Mexico Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017 Table Mexico Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017) Figure Mexico Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016 Figure Mexico Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017 Table Mexico Subcutaneous Immunoglobulins Export and Import (2012-2017) Figure North America Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2017-2022) Table North America Subcutaneous Immunoglobulins Sales Forecast by Countries (2017-2022) Table North America Subcutaneous Immunoglobulins Market Share Forecast by Countries (2017-2022) Figure United States Subcutaneous Immunoglobulins Sales Forecast (2017-2022) Figure Canada Subcutaneous Immunoglobulins Sales Forecast (2017-2022) Figure Mexico Subcutaneous Immunoglobulins Sales Forecast (2017-2022) Table North America Subcutaneous Immunoglobulins Sales Forecast by Type (2017-2022) Table North America Subcutaneous Immunoglobulins Market Share Forecast by Type (2017-2022) Table North America Subcutaneous Immunoglobulins Sales Forecast by Application (2017-2022) Table North America Subcutaneous Immunoglobulins Market Share Forecast by Application (2017-2022) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Subcutaneous Immunoglobulins Figure Manufacturing Process Analysis of Subcutaneous Immunoglobulins Figure Subcutaneous Immunoglobulins Industrial Chain Analysis Table Raw Materials Sources of Subcutaneous Immunoglobulins Major Manufacturers in 2016 Table Major Buyers of Subcutaneous Immunoglobulins Table Distributors/Traders/ Dealers List

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Report ID : MSF480673

Publisher Name : GlobalInfoResearch

Why Market Size Forecasters?

  • Reports at Lowest Prices - Guaranteed
  • Fastest Growing Research Reports’ Database
  • Easy Customization Options
  • 24 X 7 Support Commitment
  • Certified, Safe & Secured Payments

Have A Question?

Ask UsView FAQ's